Global Structural Heart Devices Market Size- By Product, By Procedure, By End User -Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Structural Heart Devices Market Introduction and Overview

According to SPER Market Research, Global Structural Heart Devices Market is estimated to reach USD 29.78 billion by 2034 with a CAGR of 9.06%.

The report includes an in-depth analysis of the Global Structural Heart Devices Market, including market size and trends, product mix, Applications, and supplier analysis. The Structural Heart Devices Market was valued at USD 12.51 billion in 2024, and it is expected to rise at a 9.06% CAGR from 2025 to 2034. Demand for structural heart devices is driven by the rising prevalence of structural heart diseases such as aortic stenosis and mitral regurgitation, particularly in aging populations. Advancements in minimally invasive technologies like TAVR and TMVR offer safer and more effective alternatives to open-heart surgery, increasing adoption. Growing awareness and improved early diagnosis of heart diseases are boosting demand for advanced therapies. Additionally, favourable reimbursement policies across several countries are supporting wider patient access, further fuelling market growth.

By Product Insights

The market is classified into heart valve devices, annuloplasty rings, occludes and delivery systems, and other products, with the heart valve devices segment generating the highest revenue. Conditions such as calcific aortic valve disease and rheumatic heart disease have a considerable healthcare impact worldwide. In the U.S., a significant share of the population suffers from heart valve disease, which is also responsible for thousands of deaths each year. These complications increase the need for efficient management and treatment, creating scope for greater utilization of heart valve devices. Furthermore, the market for advanced cardiovascular devices is supported by continuous improvements in heart valve technologies and non-invasive transcatheter replacement procedures, which are less invasive and more comfortable for patients, thereby driving market growth.

By Procedure Insights

The structural heart devices market is segmented into replacement procedures and repair procedures, with replacement procedures holding the leading share in 2024. The adoption of transcatheter heart valve replacement reflects a strong shift toward minimally invasive techniques, which are favoured by patients for their faster recovery times. Additionally, advancements in robotic-assisted heart surgery have transformed replacement approaches, allowing surgeons greater precision and control through robotic arms. Ongoing innovations in device design and procedural methods have further enhanced clinical outcomes, while key factors such as patient safety, shorter hospital stays, and improved quality of life continue to strengthen the prominence of replacement procedures in the market.

By End User Insights

The hospital segment dominated the structural heart devices market in 2024 and is expected to maintain its lead throughout the forecast period. Hospitals are equipped with advanced technologies such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), which require specialized tools and skilled expertise. Facilities with dedicated cardiac care units and interventional cardiology departments are particularly capable of performing these procedures.

Regional Insights

North America held the largest share of the structural heart devices market in 2024, driven by the growing prevalence of cardiovascular diseases, rising cases of heart valve disorders, and supportive government initiatives that boost awareness and funding for prosthetic heart valve treatments. Furthermore, The structural heart devices market in Asia Pacific is anticipated to expand at the quickest rate during the forecast period. The market is growing due to increased elderly populations, an increase in CVD incidence, and technological advancements.

Market Competitive Landscape

The structural heart devices market is highly competitive, with numerous global and regional players striving to strengthen their market positions. Leading companies such as Abbott, Medtronic, Edwards Lifesciences, and Boston Scientific hold significant shares due to their strong portfolios of transcatheter and surgical heart valve technologies. To expand their reach and capabilities, these companies actively pursue strategies like mergers and acquisitions, partnerships, and facility expansions. Continuous investment in research and development allows them to innovate device designs, improve procedural outcomes, and incorporate advanced technologies. Smaller and emerging players also focus on niche therapies and regional expansion.

Recent Developments:

The FDA approved LUMA Vision's VERAFEYE product in April 2025, providing real-time 360A° catheter navigation support for electrophysiology and structural cardiac treatments.

In November 2024, The U.S. Food and Drug Administration (FDA) granted De Novo authorization to Pi-Cardia for their unique Shortcut system. This innovative device addresses a serious coronary blockage problem and supports valve-in-valve Transcatheter Aortic Valve Replacement (TAVR) surgeries.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Procedure, By End User

Regions covered

North America, Latin America, , Europe, and Middle East & Africa

Companies Covered

Abbott, AtriCure, BIOMERICS, Boston Scientific, BRAILE, CryoLife, Edwards, JENAVALVE, LEPU, MEDICAL, LivaNova, Medtronic, NUMED.

Key Topics Covered in the Report

Global Structural Heart Devices Market Size (FY'2021-FY'2034)

Overview of Global Structural Heart Devices Market

Segmentation of Global Structural Heart Devices Market by Product (Heart valve devices, valves Annuloplasty rings, Occludes and delivery systems)

Segmentation Global Structural Heart Devices Market by Procedure (Replacement procedures, Repair procedures)

Segmentation of Global Structural Heart Devices Market by End User (Hospitals Ambulatory surgical centres, Cardiac catheterization labs, Other end user)

Statistical Snap of Global Structural Heart Devices Market

Expansion Analysis of Global Structural Heart Devices Market

Problems and Obstacles in Global Structural Heart Devices Market

Competitive Landscape in the Global Structural Heart Devices Market

Details on Current Investment in Global Structural Heart Devices Market

Competitive Analysis of Global Structural Heart Devices Market

Prominent Players in the Global Structural Heart Devices Market

SWOT Analysis of Global Structural Heart Devices Market

Global Structural Heart Devices Market Future Outlook and Projections (FY'2025-FY'2034)

Recommendations from Analyst